Watch the video series here.
Valensa International introduces a new Saw Palmetto video series, featuring Chief Science Officer Margaret H. Dohnalek, PhD. Dr. Dohnalek describes the breadth of research on saw palmetto lipidosterolic extract derived from this special berry, and the scientific evidence for a standardized extract that supports a healthy prostate.
The video series entitled “Importance of a Standardized Lipid Extract of Saw Palmetto,” uncovers research from around the world that explains the role of a standardized lipid extract to support the prostate gland and Lower Urinary Tract Symptoms (LUTS) in men, which include weak stream, hesitancy, straining to urinate, and urinary retention.
Additionally, Dr. Dohnalek explains the difference between the effectiveness of unripe saw palmetto berry powder and saw palmetto lipidosterolic extracts that work. Dr. Dohnalek joined Valensa International in 2018, bringing over 30 years of expertise leading nutritional innovations for Fortune 500 companies, including PepsiCo, Pfizer and Abbott Laboratories. She is named on six issued US patents, has authored 18 scientific papers and a book chapter, and given scientific presentations in 21 countries related to nutrition. She earned a Ph.D. in Food Toxicology with a minor in Medical Microbiology and Preventive Medicine from the University of Wisconsin-Madison.
Designed as an overview for customer engagement, each segment of the four part series is less than two minutes long. Segments will be released weekly during the month of August. Watch them here and email email@example.com for more information.